FDA Adverse Event Injury Summary report: N

THERMOCOOL® SF NAV BI-DIRECTIONAL CATHETER

MDR report key: 3131880 · Received May 29, 2013

Report

Report Number
9673241-2013-00173
Event Type
Injury
Date Received
May 29, 2013
Date of Event
May 6, 2013
Report Date
May 6, 2013
Manufacturer
BIOSENSE WEBSTER, INC. (JUAREZ)
Product Code
LPB
PMA / PMN Number
P030031/S025
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). IT WAS REPORTED THAT 1.5 HOURS INTO AN ATRIAL FIBRILLATION (A-FIB) PROCEDURE, THE PATIENT SUFFERED A PERICARDIAL EFFUSION THAT WAS NOTICED ON INTRACARDIAC ECHOCARDIOGRAPHY (ICE) AFTER THE PATIENT'S BLOOD PRESSURE DROPPED. THE PHYSICIAN DIDN¿T CONSIDER THAT THE EVENT¿S CAUSALITY WAS DUE TO ANY MALFUNCTION OF BWI PRODUCTS. THE RETURNED DEVICE WAS VISUALLY INSPECTED UPON RECEIPT AND IT WAS FOUND IN NORMAL CONDITIONS. PER THE EVENT, THE CATHETER WAS TESTED FOR ELECTRICAL PERFORMANCE, TEMPERATURE RESPONSE AND STOCKERT COMPATIBILITY AND IT WAS FOUND WITHIN SPECIFICATIONS. FURTHERMORE, A COOL FLOW PUMP TEST WAS ALSO PERFORMED AND THE CATHETER PASSED SPECIFICATIONS. THE CATHETER WAS ALSO EVALUATED FOR EEPROM, CARTO 3, 4 KHZ AND CALIBRATION FUNCTIONALITY. THE CATHETER WAS RECOGNIZED BY CARTO 3 SYSTEM, NO ERROR MESSAGES WERE DISPLAYED AND THE CATHETER WAS PROPERLY VISUALIZED. EEPROM DATA DEMONSTRATES THE CATHETER WAS PROPERLY CALIBRATED DURING MANUFACTURING. FINALLY, A DEFLECTION TEST WAS PERFORMED AND THE CATHETER PASSED. THE CATHETER PASSED ALL SPECIFICATIONS. THE ROOT CAUSE OF THE PERICARDIAL EFFUSION REMAINS UNKNOWN. THE DEVICE HISTORY RECORD (DHR) WAS REVIEWED AND NO ANOMALIES WERE FOUND RELATED TO THIS COMPLAINT. IN ADDITION, THE DHR REVIEW VERIFIES THAT THE DEVICE WAS MANUFACTURED IN ACCORDANCE WITH DOCUMENTED SPECIFICATION AND PROCEDURES. THE IFU STATES THAT CAREFUL CATHETER MANIPULATION MUST BE PERFORMED IN ORDER TO AVOID CARDIAC DAMAGE, PERFORATION OR TAMPONADE.

Additional Manufacturer Narrative · 1

INVESTIGATION IS STILL IN PROCESS. A 3500A SUPPLEMENTAL REPORT WILL BE SUBMITTED TO THE FDA ONCE THAT PRODUCT ANALYSIS INVESTIGATION IS COMPLETED. CONCOMITANT PRODUCTS: CARTO 3 SYSTEM: U.S. CATALOG #: FG540000, SERIAL #: (B)(4). STOCKERT 70 SYSTEM: U.S. CATALOG #: S7001, SERIAL #: (B)(4). COOL FLOW PUMP: U.S. CATALOG #: CFP002, SERIAL #: (B)(4). REPROCESSED SOUNDSTAR CATHETER. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT 1.5 HOURS INTO AN ATRIAL FIBRILLATION (A-FIB) PROCEDURE, THE PATIENT SUFFERED A PERICARDIAL EFFUSION THAT WAS NOTICED ON INTRACARDIAC ECHOCARDIOGRAPHY (ICE) AFTER THE PATIENT'S BLOOD PRESSURE DROPPED. THE PHYSICIAN HAD BEEN ABLATING AT 40 WATTS WITH A THERMOCOOL SF NAV BI-DIRECTIONAL CATHETER AND THE FLOW RATE OF THE COOL FLOW PUMP WAS 15 ML/MIN. AFTER FOLLOW UP WITH THE CUSTOMER TO GET DETAILED INFORMATION REGARDING THE EVENT IT WAS CONFIRMED THAT PERICARDIOCENTESIS WAS PERFORMED. THE OUTCOME OF THE ADVERSE EVENT WAS REPORTED AS FULLY RECOVERED AND ACCORDING WITH THE LAB STAFF THE PROGNOSIS OF THE PATIENT WAS GOOD. THE PHYSICIAN¿S OPINION REGARDING THE CAUSALITY OF ADVERSE EVENT WAS POSSIBLE PROCEDURE RELATED. THE PHYSICIAN DIDN¿T CONSIDER THAT THE EVENT¿S CAUSALITY WAS DUE TO ANY MALFUNCTION OF BWI PRODUCTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
237246 THERMOCOOL® SF NAV BI-DIRECTIONAL CATHETER CARDIAC ABLATION PERCUTANEOUS CATHETER LPB BIOSENSE WEBSTER, INC. (JUAREZ) D-1313-04-S 15841618L

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| L| R